3 transcripts
APLS
Earnings call transcript
NASDAQ
2024 Q2
1 Aug 24
in GA as well. That there are advantages to treating monthly, right? I mean, it is more intense from a dosing perspective, of course.
But in terms
APLS
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
% of the treated patients at week 12 and reductions by one or more magnitude of intensity in 80% of treated patients. We plan to share the 52-week data from
APLS
Earnings call transcript
NASDAQ
2023 Q2
31 Jul 23
, of course, an intense couple of weeks for us. But we are very happy with how we come out of ASRS because we believe that we have gained significant
- Prev
- 1
- Next